Clinical Trials Browser

Phase 2 × Not yet recruiting × Advanced Non-Small Cell Lung Cancer × Clear all

NCT07415005 2026-02-17

Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung Cancer

Phase 2 Not yet recruiting

Advanced Non-Small Cell Lung Cancer